Sofia Magina
Overview
Explore the profile of Sofia Magina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Torres T, Magina S, Paiva Lopes M
J Dermatolog Treat
. 2025 Jan;
36(1):2453601.
PMID: 39870388
Introduction: Psoriasis (PsO) is a common chronic, inflammatory, immune-mediated disease. In 2023, a 4.4% prevalence of PsO was reported in Portugal. Currently, Tumor Necrosis Factor inhibitors (TNFi) are the recommended...
2.
Henriques A, Pimentel-Santos F, Teles de Sousa J, Silva L, Gago L, Emilia Santos M, et al.
ARP Rheumatol
. 2025 Jan;
3(4):258-267.
PMID: 39754727
Background: The percentage of Portuguese psoriasis patients with psoriatic arthritis is unknown but musculoskeletal complaints related to PsA affect up to a third of patients. Dermatologists can identify early PsA...
3.
Torres T, Antunes J, Brasileiro A, Alves J, Bernardo D, Ramos J, et al.
J Dermatolog Treat
. 2024 Apr;
35(1):2345728.
PMID: 38684228
Objectives: Generalized pustular psoriasis (GPP) is a rare, life-threatening skin inflammatory disorder. This study aimed to describe the disease course, treatment strategies, and healthcare utilization among patients with GPP in...
4.
Teixeira A, Teixeira M, Gaio R, Torres T, Magina S, Dinis M, et al.
Healthcare (Basel)
. 2024 Apr;
12(8).
PMID: 38667584
(1) Background: Psoriasis is a common chronic inflammatory skin disease with different manifestations, affecting the quality of life at social, emotional, and professional dimensions and requiring long-term treatment. This study...
5.
Granja B, Amoedo P, Gomes N, Costa C, Azevedo F, Magina S
An Bras Dermatol
. 2024 Apr;
99(4):642-644.
PMID: 38653608
No abstract available.
6.
Torres T, Varela P, Bastos P, Magina S, Henrique M, Ferreira P
Drugs Context
. 2024 Mar;
13.
PMID: 38510314
Background: Real-world evidence plays a pivotal role in validating the efficacy of biologic drugs beyond the controlled environment of randomized trials. This study aimed to evaluate the effectiveness of tildrakizumab...
7.
Amoedo P, Cerejeira A, Moreira F, Coelho A, Barros A, Moreira E, et al.
Eur J Dermatol
. 2023 Aug;
33(3):241-244.
PMID: 37594329
Background: Hidradenocarcinoma is a rare malignant sweat gland tumour, characterized by a slow but aggressive course, with high rates of local recurrence and metastasis. Due to its rarity, histological criteria...
8.
Fernandes T, Magina S
Cutan Ocul Toxicol
. 2023 Jun;
42(3):83-90.
PMID: 37343232
Purpose: Acne vulgaris is a very prevalent dermatological condition, especially among adolescents and young adults up to 25 years old, classifying it as juvenile acne. One of the most effective...
9.
Correia G, Magina S
J Cosmet Dermatol
. 2023 May;
22(7):1938-1945.
PMID: 37128827
Background: Vitamin C is a micronutrient present in high concentrations in normal skin and a highly prescribed cosmeceutical, well known for protecting against ultraviolet-induced pigmentation and regulating collagen production. However,...
10.
Amoedo P, Matos P, Magina S
Eur J Dermatol
. 2023 Mar;
32(6):820-822.
PMID: 36856405
No abstract available.